Clough Capital Partners’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-94,050
Closed -$8.64M 144
2021
Q4
$8.64M Buy
+94,050
New +$11.2M 0.58% 53
2021
Q3
Sell
-6,447
Closed -$1.07M 143
2021
Q2
$1.07M Sell
6,447
-2,145
-25% -$348K 0.06% 105
2021
Q1
$1.56M Sell
8,592
-14,933
-63% -$3.46M 0.07% 103
2020
Q4
$4.7M Sell
23,525
-61,689
-72% -$12.5M 0.33% 71
2020
Q3
$18.7M Buy
85,214
+14,210
+20% +$3.01M 1.34% 27
2020
Q2
$13.6M Sell
71,004
-19,790
-22% -$3.47M 1.33% 22
2020
Q1
$14.1M Sell
90,794
-27,820
-23% -$3.24M 1.4% 21
2019
Q4
$9.93M Sell
118,614
-22,400
-16% -$1.7M 0.85% 47
2019
Q3
$9.55M Sell
141,014
-6,914
-5% -$455K 0.79% 36
2019
Q2
$9.82M Sell
147,928
-43,300
-23% -$2.52M 0.96% 39
2019
Q1
$10.6M Buy
191,228
+91,100
+91% +$5.56M 0.93% 35
2018
Q4
$4.96M Buy
100,128
+3,428
+4% +$210K 0.58% 61
2018
Q3
$8.35M Sell
96,700
-40,800
-30% -$2.91M 0.79% 47
2018
Q2
$7.98M Sell
137,500
-132,200
-49% -$6.46M 0.71% 46
2018
Q1
$10.9M Buy
+269,700
New +$10.2M 1.04% 32

Other funds holding TDOC

Clough Capital Partners's TDOC Position: Q1 2022 in Review

Clough Capital Partners sold out of Teladoc Health (TDOC) in Q1 2022, closing a stake of 94,050 shares — an estimated $8.64M sold.

Clough Capital Partners first reported a position in TDOC in Q1 2018 and held it in 15 quarters. The position peaked at $18.7M in Q3 2020. 680 funds tracked by Wall St. Rank hold TDOC as of Q1 2022.

  • Clough Capital Partners reported no remaining Teladoc Health position as of Q1 2022 after selling out during the quarter.
  • Clough Capital Partners sold 94,050 Teladoc Health shares in Q1 2022, an estimated $8.64M.
  • Clough Capital Partners first reported a position in Teladoc Health in Q1 2018 and held it in 15 quarters.
  • Clough Capital Partners's Teladoc Health position peaked at $18.7M in Q3 2020.
  • 680 funds tracked by Wall St. Rank held Teladoc Health as of Q1 2022.

Based on Clough Capital Partners's 13F filing for Q1 2022, filed 16 May 2022.